Literature DB >> 6367691

Diazepam and propranolol in panic disorder and agoraphobia.

R Noyes, D J Anderson, J Clancy, R R Crowe, D J Slymen, M M Ghoneim, J V Hinrichs.   

Abstract

The response to diazepam and propranolol hydrochloride was compared in 21 patients who (with one exception) met DSM-III criteria for panic disorder and agoraphobia. Each drug was administered for two weeks in double-blind fashion according to a crossover design. The response to diazepam was significantly superior on all measures. By observer rating, 18 patients showed at least moderate improvement with diazepam compared with seven receiving propranolol. Panic attacks and phobic symptoms responded to diazepam, but not to propranolol. The results suggest that benzodiazepines constitute effective short-term treatment for these newly defined disorders.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6367691     DOI: 10.1001/archpsyc.1984.01790140077009

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  13 in total

Review 1.  Current status of beta-blocking drugs in the treatment of anxiety disorders.

Authors:  P Tyrer
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 2.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 3.  The utility of the panic disorder concept.

Authors:  D F Klein; H M Klein
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

4.  Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat.

Authors:  D J Fontana; T J Carbary; R L Commissaris
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  The use of antidepressant drugs in general practice. A questionnaire survey.

Authors:  K Matthews; J M Eagles; C A Matthews
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 6.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

7.  Effects of acute and chronic imipramine administration on conflict behavior in the rat: a potential "animal model" for the study of panic disorder?

Authors:  D J Fontana; R L Commissaris
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs.

Authors:  H E Molewijk; A M van der Poel; J Mos; J A van der Heyden; B Olivier
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

9.  Drug treatment of phobias. Efficacy and optimum use.

Authors:  A P Levin; M R Liebowitz
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

Review 10.  Panic disorder. Pathophysiology and drug treatment.

Authors:  M R Johnson; R B Lydiard; J C Ballenger
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.